Dr. Shubham Pant & others discuss basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC) type cancers its therapy. These experts reflect on potential benefit with PD-1–targeted therapy in the settings in this kind of cancers.
Dr. Samir Patel says HPV in the throat and mouth is rising at an epidemic level where tumors in these locations have outpaced those from smoking. A type of radiation treatment called proton beam therapy offers some advantages.
Karim Fizazi gives highlights on the updated findings from the phase III ARAMIS trial using darolutamide for the treatment of patients with nonmetastatic castration-resistant prostate cancer (nmCRPC).
Recent advancements in knee replacement surgery are showing major benefits to the patient. The total knee advances are implants & the ability to do a CT and an MRI beforehand in order to get patients a specific implant. Other improvements are helping patients better manage the pain after surgery. With new advancements, patients are now getting out of the hospital just hours after the procedure.
M. Scott Lucia, MD, reviews the historical utilization of the Gleason grading score as an indicator of prostate cancer prognosis and the refinements the system has undergone to improve predictive accuracy. He examines changes to the grading of cribriform carcinoma, as well as an improved 5-tier grade classification system.
Justine Lee, MD, plastic and reconstructive surgeon, gives an overview of surgical techniques for facial reconstruction to support the profound journey of transgender patients.
UC Davis associate professor Tara A. Niendam, Ph.D., describes appropriate assessment tools and approaches to treating trauma in individuals with psychosis.
Dr. John Stulak, a Mayo Clinic cardiovascular surgeon, discusses ventricular assist devices (VAD)s and heart transplant. When one of the heart's natural pumps isn’t working well, a VAD can be used to increase the amount of blood that flows through the body.
The video shows the importance of the visual health record to the patient journey, unique challenges faced by administrators and providers alike when managing medical imaging, how a facility can image-enable your EHR, eliminating the need to toggle between systems while reducing error and speeding up time-to-care delivery along the way.
Dr. Girard discusses the rationale for the PACIFIC-R study, which is examining patients with unresectable stage III non–small cell lung cancer (NSCLC) who received durvalumab (Imfinzi). PACIFIC-R is a retrospective collection of data from patients who received durvalumab as a consolidation treatment for unresectable stage III NSCLC. The study looks to validate the benefit of durvalumab consolidation in a real-life setting using data from the PACIFIC trial.